3-((Benzyloxy)methyl)-4-ethyl-1H-1,2,4-triazol-5(4H)-one, 98%, 100mg

5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole, 95.0%, 250mg

Levocetirizine Dihydrochloride>98.0%(HPLC)(T)1g

4,4,5,5-Tetramethyl-2-(5-methylfuran-2-yl)-1,3,2-dioxaborolane, 95.0%, 10g

2-(4-morpholinyl)propanohydrazide dihydrochloride, 95.0%, 5g

7-Bromo-4-chloro-8-methylquinoline, 97%, 5g

4-Bromo-1-ethynyl-2-(trifluoromethyl)benzene, 97%, 100mg

Colonna capillare per GC ROTI®Cap-5, 10 m, 0.53 mm, 2.00 µm, 1 Pezzo(i)

2-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetonitrile, 95.0%, 5g

(R)-2-Thiophen-2-ylthiazolidine-4-carboxylic acid, 95.0%, 1g

Acetato di manganese(II), tetraidrato (base metallica) 99,999% 50 g

trans-1-Methyl-4-carboxy-5-(3-pyridyl)-2-pyrrolidinone>95.0%(GC)(T)5g

1,4-Diiodo-2,3,5,6-tetramethylbenzene, 95.0%, 1g